GemVax & KAEL (South Korea)

Recent papers from GemVax & KAEL (South Korea)

1. GV1001 reduces pathological 4R tau and functional deficits in models relevant to progressive supranuclear palsyScientific Reports · 2026
2. Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trialBritish Journal of Cancer · 2023
3. Association between sleep parameters and longitudinal shortening of telomere lengthAging · 2022
4. Serum neurofilament light chain level as a predictor of cognitive stage transitionAlzheimer s Research & Therapy · 2022
5. Relationship between telomere shortening and age in Korean individuals with mild cognitive impairment and Alzheimer’s disease compared to that in healthy controlsAging · 2020
6. Relationship Between Daily Sedentary Behaviors and Metabolic Syndrome in Middle-Aged Adults: Results from a Health Survey in Taean-Gun, Republic of KoreaMetabolic Syndrome and Related Disorders · 2020
7. An Optimized Adsorbent Sampling Combined to Thermal Desorption GC-MS Method for Trimethylsilanol in Industrial EnvironmentsInternational Journal of Analytical Chemistry · 2012
8. Hetastarch reduces neuronal cell death caused by oxidative stressDrug Development Research · 2011